Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesity
Source: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesity
Source: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates